-
FDA Clears First Blood Test for Concussions
The Food and Drug Administration authorized for marketing in the U.S. a blood test that screens for chemical indicators in the blood for concussions, a form of traumatic brain injury.
-
Lab Burns Graphene Circuits into Food, Fabrics
A chemistry lab at Rice University devised a process for producing graphene, a material that conducts electricity, in materials containing carbon, including fabrics and even food.
-
Patents Awarded for Genetic Editing of CAR T-Cells
U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells.
-
Engineered Virus Shows Promise in Some Brain Tumors
A clinical trial testing a common virus modified to generate a specific immune response dramatically reduced deadly brain tumors in a small group of patients and extended their survival for years, but most other patients had only limited success.
-
Cardiac Augmented-Reality Hologram System in Development
A start-up company spun-off from Washington University in St. Louis was awarded a grant to advance an augmented reality system that displays an interactive hologram of a patient’s heart, to simplify cardiac procedures.
-
Report – Industry Pain, Addiction Drug Efforts Flagging
A report by a biotechnology industry organization says development efforts and financing for new drugs to treat pain and addiction are falling behind the health and safety needs of society.
-
Infographic – Software Security Risks at Record Level
This weekend’s infographic is from our friends at Statista who published a recent chart showing the almost constant rise in security risks since 2010 due to software, recorded by Hasso-Plattner-Institute in Germany.
-
Securing Your Small Business’s Profit
Unfortunately, if you don’t take the right steps, others will be able to directly copy your work and profit from it and there won’t be a whole lot that you can do.
-
Biotechs Collaborate on Immunotherapies in $1.2B Deal
Two biotechnology companies developing cancer therapies harnessing the immune system are partnering on new treatments for solid tumor and blood-related cancers.
-
Business Investment – Wealth Rules Backed By Science
You don’t want to be the kind of person who doesn’t use the facts to their advantage as it’s a sure-fire way to fail.